entertainment -WSS

entertainment

author：fashion 2025-10-01 23:59:12 - browse：66973

FDA's Peter Marks talks with STAT's Adam Feuerstein — Peter Marks, the FDA's top regulator of gene therapies (right), speaks with STAT's Adam Feuerstein in San Francisco. Sarah Gonzalez/Peopletography for STAT

SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies, seems very comfortable with granting some form of full approval to Elevidys, the Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy, based on his comments to me on Monday night during our “fireside chat” at a STAT event.

To be clear, Marks declined to comment specifically about the ongoing FDA review of Elevidys. I tried. However, Marks described a “hypothetical case” in the context of my Sarepta questions that clearly suggested the failure of an Elevidys confirmatory study in October didn’t bother him all that much.

“Hypothetically, if you had a product that used an aggregate scale and all of the components of that aggregate scale looked pretty good, or nearly all of them look pretty good, but the aggregate, for various reasons, didn’t come out perfectly. We approved products based on that,” Marks told me.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

WSS

FDA approves RSV monoclonal antibody for infants, toddlers

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Biogen joins immunology wave with $1.15 billion acquisition of HI

As digital health tech proliferates, a new institute aims to cut through hype

hotspot

entertainment

leisure time

Hollywood unions extend contract negotiations for actors

Fentanyl is making it harder to start addiction treatment

At least 13 dead in Texas as scorching temps continue

WHO calls for emergency meeting on new China virus, as cases spread

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Sanders adds drug shortage policies to pandemic preparedness bill

What does generative AI mean for health care? We asked experts

Sanofi seeks simpler, safer CRISPR sickle cell cure

Medicare proposal to cover medical devices draws a mixed reaction

Listen: Wegovy in the brain & pivotal Alzheimer's data

knowledge

Biden tests positive for Covid

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Why hospitals are withdrawing from US News rankings

As a primary care physician, here's how I hope to partner with AI

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Bird flu surveillance in wastewater gets boost from consortium

focus

focus

entertainment

hotspot